Firas Ershaid, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

None Reported

None Reported

P-283 Predictors of oxaliplatin-induced hepatotoxicity: Increase in spleen volume or liver fibrosis and steatosis
Annals of Oncology
2019 Jul 1
Date: 07 2019
www.researchgate.net/publication/334184607_P-283Predictors_of_oxaliplatin-induced_hepatotoxicity_Inc

Imaging Modalities Employed in the TAVR Procedure With a Focus on CTA: What the Radiologist Needs to Know
ElSevier ScienceDirect
Volume: -
Date: 09 2021
doi.org/10.1016/j.acra.2021.08.012